Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Erin K. Meyer"'
Autor:
Elizabeth P. Crowe, Jennifer Andrews, Erin K. Meyer, Ruchika Goel, Trisha E. Wong, Steven R. Sloan, Lani Lieberman, Melissa M. Cushing, Meghan Delaney
Publikováno v:
TransfusionREFERENCES. 61(4)
Background We hypothesized that variability in practice exists for newborn immunohematology testing due to lack of consensus guidelines. We report the results of a survey assessing that variability at hospitals in the United States and Canada. Study
Autor:
Kimberly W. Sanford, Sarita Joshi, Erin K. Meyer, Edward C.C. Wong, Tina S. Ipe, Jay S. Raval
Publikováno v:
Journal of clinical apheresisREFERENCES. 36(1)
Therapeutic plasma exchange is used to treat neurological diseases in the pediatric population. Since its first use in pediatric patients with hepatic coma in the form of manual whole blood exchange, therapeutic plasma exchange has been increasingly
Publikováno v:
American Journal of Clinical Pathology. 151:116-121
Objectives Knowledge of transfusion medicine by medical students is limited. Transfusion medicine physicians developed, implemented, and evaluated a half-day elective on transfusion medicine for fourth-year medical students. Methods The course includ
Publikováno v:
ASAIO Journal. 64:382-388
The epidemiology, safety, and efficacy of pediatric multiple tandem extracorporeal therapies are not well understood. We conducted a retrospective chart review of therapeutic apheresis (TA) from January 1, 2012 to October 31, 2015. We collected proce
Autor:
Jonathan Pindrik, Summit H. Shah, Priyal Patel, Jennifer H. Aldrink, Erin K. Meyer, Jeffery J. Auletta, Mohammad H Abu Arja, Suzanne Conley, Mohamed S. AbdelBaki
Publikováno v:
World Neurosurgery. 111:6-15
Background Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) with synchronous or metachronous extra-CNS disease is a rare childhood malignancy with a dismal prognosis. Case Description We report a 7-week-old female with met
Publikováno v:
Journal of Clinical Apheresis. 33:297-302
INTRODUCTION Therapeutic apheresis (TA) is used inconsistently in pediatric populations. We seek to define our multidisciplinary institutional practice. METHODS We conducted a retrospective chart review of patients receiving TA from January 1, 2012 t
Autor:
Cassandra D. Josephson, Howard M. Gebel, Harold Cliff Sullivan, John D. Roback, Erin K. Meyer, Ross M. Fasano, Sean R. Stowell, Annie M. Winkler, Robert A. Bray, Alexander Sandy Duncan
Publikováno v:
Archives of Pathology & Laboratory Medicine. 141:329-340
Current genotyping methodologies for transplantation and transfusion management employ multiplex systems that allow for the simultaneous detection of multiple human leukocyte antigens (HLA), human platelet antigens (HPA) and red blood cell (RBC) anti
Autor:
Michael F. Murphy, Padmakumari Abeysinghe, Agneta Wikman, Best Collaborative, Catherine Eppes, Stephen P. Emery, Richard M. Kaufman, Leo M.G. van de Watering, Alyssa Ziman, Sarah K. Harm, Meghan Delaney, Andreas Buser, Julie Staves, Mark H. Yazer, Aicha N Traore, Helen Savoia, Henk Schonewille, Erin K. Meyer, Mark K. Fung, Susanne Flach, Alan Tinmouth, Nancy M. Heddle, Nancy M. Dunbar, Donald M. Arnold, Jennie P Verdoes
Publikováno v:
Transfusion. 57:525-532
Background Red blood cell (RBC) antigen matching policies to prevent alloimmunization in females of childbearing potential (FCP) vary between centers. To inform transfusion centers responsible for making decisions about matching policies for FCPs, th
Autor:
Ross M. Fasano, Erin K. Meyer, Marianne E. McPherson Yee, Peter A. Lane, Angela G. Brega, Cassandra D. Josephson
Publikováno v:
Pediatric bloodcancer. 66(7)
BACKGROUND Patients with sickle cell disease (SCD) may require chronic transfusion therapy (CTT) for prevention of stroke or other complications. Limited health literacy (HL) is common and is associated with poor health-related knowledge and outcomes
Autor:
Mark Ranalli, Diana S Osorio, Jennifer H. Aldrink, Elizabeth Varga, Catherine E. Cottrell, Kristen M. Leraas, Jeremy Jones, Priyal Patel, Aaron S. McAllister, Lisa Martin, Katherine E. Miller, Mohamed S. AbdelBaki, Summit H. Shah, Vincent Magrini, Suzanne Conley, Margaret Shatara, Stephanie LaHaye, Jeffrey R. Leonard, Jonathan Pindrik, Jonathan L. Finlay, Kathleen M. Schieffer, Christopher R. Pierson, Tara M. Lichtenberg, Jeffery J. Auletta, Erin K. Meyer, Elaine R. Mardis, Ajay Gupta, Mohamed H Abu Arja, Daniel R. Boue, Richard K. Wilson, Diana L Thomas
Publikováno v:
Neuro-Oncology
BACKGROUND Rhabdoid predisposition syndrome is characterized by germline alterations in SMARCB1 or SMARCA4, leading to synchronous or metachronous central nervous system (CNS) and extra-CNS rhabdoid tumors. Rare survivors have been reported to date.